Aurora Cannabis Inc ACB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Aurora Named to TIME Canada's Best Companies 2026 List
-
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
-
Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹
-
Aurora Deepens its Impact for Veterans Across Canada
-
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2026 Investor Conference Call and File Related Year End Information
-
Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science
-
Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets
-
Canadian Cannabis Stocks Jump on Report U.S. May Move to Reclassify Marijuana
Trading Information
- Previous Close Price
- $2.67
- Day Range
- $2.63–2.70
- 52-Week Range
- $2.63–6.66
- Bid/Ask
- $2.66 / $2.67
- Shares Outstanding
- 61.94M
- Market Cap
- $164.22M
- Volume/Avg
- 566,070 / 1M
Key Statistics
- Price/Earnings (Normalized)
- 28.50
- Price/Sales
- 0.65
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,101
- Website
- https://www.auroramj.com
Valuation
|
Metric
|
ACB
|
|---|---|
Price/Earnings (Normalized) | 28.50 |
Price/Book Value | 0.43 |
Price/Sales | 0.65 |
Price/Cash Flow | 151.01 |
Price/Earnings
ACB
Financial Strength
|
Metric
|
ACB
|
|---|---|
Quick Ratio | 2.41 |
Current Ratio | 5.94 |
Interest Coverage | −33.48 |
Quick Ratio
ACB
Profitability
|
Metric
|
ACB
|
|---|---|
Return on Assets (Normalized) | −5.25% |
Return on Equity (Normalized) | −7.44% |
Return on Invested Capital (Normalized) | −6.66% |
Return on Assets
ACB
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|tx<gR%^ | LOCK|vK!v | $69B | |||
| Haleon PLC ADR
HLN
| LOCK|fF>Vld$ | LOCK|C@H | $43B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|rtrkRxy | LOCK|%k<>L | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|cNjQHgzy | LOCK|N?$ | $32B | |||
| Viatris Inc
VTRS
| LOCK|sPM!Rx | LOCK|^# | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|^W | LOCK|<<P | $13B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|G&>MwVH | LOCK|kgt | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|ZR!SG^Z | LOCK|GT | $8B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|K&>^NR | LOCK|cKLT^ | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|J?!Rt^F | LOCK|#Jk | $1B |
United States